Latest Neuraminidase inhibitors Stories

2010-01-13 06:00:00

BIRMINGHAM, Ala., Jan. 13 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its partner, Shionogi & Co., Ltd. has received marketing and manufacturing approval for intravenous (i.v.) peramivir to treat patients with influenza in Japan.

2010-01-12 06:00:00

BIRMINGHAM, Ala., Jan. 12 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.

2010-01-11 06:00:00

BIRMINGHAM, Ala., Jan. 11 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.

2010-01-08 06:00:00

BIRMINGHAM, Ala., Jan. 8 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.

2010-01-07 09:00:00

SAN DIEGO, Jan. 7 /PRNewswire/ -- NexBio, Inc. announced today the initiation of a double blind placebo controlled multi-center trial in the U.S. and Mexico of DAS181 (Fludase®) for the treatment of laboratory confirmed influenza infection.

2009-12-06 13:56:25

A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies.

2009-12-03 11:22:00

NEW YORK, Dec. 3 /PRNewswire/ -- According to the World Health Organization, the human H1N1/09 Type A influenza ("Swine Flu") has reached a pandemic level. Over 500,000 cases have been confirmed worldwide with at least 6,500 fatalities.

2009-12-02 09:30:00

SOUTH SAN FRANCISCO, Calif., Dec. 2 /PRNewswirel/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has begun shipping additional quantities of Tamiflu® (oseltamivir phosphate) oral suspension (liquid).

Word of the Day
  • An uxorious, effeminate, or spiritless man.
  • A timorous, cowardly fellow.
Probably a blend of meek and cock, or from meek +‎ -ock (“diminutive suffix”).